Three Fool.com contributors believe they've identified truly magnificent growth stocks to buy right now. Here's why they chose AstraZeneca (NASDAQ: AZN), Eli Lilly (NYSE: LLY), and Vertex Pharmaceuticals (NASDAQ: VRTX). David Jagielski (AstraZeneca): What makes AstraZeneca a magnificent long-term investment is how broad the business is and the potential it has to generate long-term gains.
(Bloomberg) -- The global market for novel weight-loss drugs like Novo Nordisk A/S’s Ozempic and Wegovy is poised to reach $100 billion by 2035 as patients start to understand the efficacy of the medications.Most Read from BloombergChinese Gold Buying Is Driving a Paradigm Shift in BullionStocks Flash Recession Warning as Trouble Spreads to IndustrialsWells Fargo Preps for Wealth Battle After $1 Billion TurnaroundBond Market Faces Quandary After Fed Signals It’s Almost DoneUS to Keep a Distance
Based on analysts' projections, you might think the pharmaceutical giant isn't worth investing in right now.